Drugs / Arm A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07863869 | Sep 2026 → May 2029 expected | colorectal cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arm A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07863869 ↗ |
| Route | Intravenous | “LV 400mg/m², IV, D1, Q2W, for a maximum of 2 years.” NCT07863869 ↗ |